Results at a single centre of immunosuppression with cyclosporine A in 66 children with aplastic anaemia

Alexei Maschan, Natalia Bogatcheva, Oleg Kryjanovskii, Maria Shneider, Dimitry Litvinov, Tatiana Mitiushkina, Andrei Timakov, Maria Timakova, Elena Samotchatova, Alexander Rumiantsev

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

A retrospective analysis of cyclosporine A (CsA) monotherapy administered to 66 children with aplastic anaemia (AA) at a single centre was carried out. The study was conducted on 66 children (F34/M32) with a median age of 10.5 years. 30 children (45%) achieved complete or partial remission within a median of 8 weeks. The response rate was 3/19 (16%) in cases of very severe aplastic anaemia (vSAA), 16/34 (47%) in severe aplastic anaemia (SAA) and 11/13 (85%) in nonSAA. 10 remitters (33%) relapsed after CsA cessation or dose tapering and six of those responded again on CsA alone. The only variable predictive for response was granulocyte count before treatment. The actuarial probability of survival was 51% at 4 years (85% in moderate AA, 50% in SAA and 32% in vSAA). The optimal dosage of CsA has yet to be established.

Original languageEnglish (US)
Pages (from-to)967-970
Number of pages4
JournalBritish journal of haematology
Volume106
Issue number4
DOIs
StatePublished - Oct 13 1999

Fingerprint

Aplastic Anemia
Immunosuppression
Cyclosporine
Granulocytes

Keywords

  • Aplastic anaemia
  • Children
  • CsA trough level
  • Cyclosporine A
  • Immunosuppression

ASJC Scopus subject areas

  • Hematology

Cite this

Results at a single centre of immunosuppression with cyclosporine A in 66 children with aplastic anaemia. / Maschan, Alexei; Bogatcheva, Natalia; Kryjanovskii, Oleg; Shneider, Maria; Litvinov, Dimitry; Mitiushkina, Tatiana; Timakov, Andrei; Timakova, Maria; Samotchatova, Elena; Rumiantsev, Alexander.

In: British journal of haematology, Vol. 106, No. 4, 13.10.1999, p. 967-970.

Research output: Contribution to journalArticle

Maschan, A, Bogatcheva, N, Kryjanovskii, O, Shneider, M, Litvinov, D, Mitiushkina, T, Timakov, A, Timakova, M, Samotchatova, E & Rumiantsev, A 1999, 'Results at a single centre of immunosuppression with cyclosporine A in 66 children with aplastic anaemia', British journal of haematology, vol. 106, no. 4, pp. 967-970. https://doi.org/10.1046/j.1365-2141.1999.01650.x
Maschan, Alexei ; Bogatcheva, Natalia ; Kryjanovskii, Oleg ; Shneider, Maria ; Litvinov, Dimitry ; Mitiushkina, Tatiana ; Timakov, Andrei ; Timakova, Maria ; Samotchatova, Elena ; Rumiantsev, Alexander. / Results at a single centre of immunosuppression with cyclosporine A in 66 children with aplastic anaemia. In: British journal of haematology. 1999 ; Vol. 106, No. 4. pp. 967-970.
@article{944289b89f1a41da8117f57dc97b6735,
title = "Results at a single centre of immunosuppression with cyclosporine A in 66 children with aplastic anaemia",
abstract = "A retrospective analysis of cyclosporine A (CsA) monotherapy administered to 66 children with aplastic anaemia (AA) at a single centre was carried out. The study was conducted on 66 children (F34/M32) with a median age of 10.5 years. 30 children (45{\%}) achieved complete or partial remission within a median of 8 weeks. The response rate was 3/19 (16{\%}) in cases of very severe aplastic anaemia (vSAA), 16/34 (47{\%}) in severe aplastic anaemia (SAA) and 11/13 (85{\%}) in nonSAA. 10 remitters (33{\%}) relapsed after CsA cessation or dose tapering and six of those responded again on CsA alone. The only variable predictive for response was granulocyte count before treatment. The actuarial probability of survival was 51{\%} at 4 years (85{\%} in moderate AA, 50{\%} in SAA and 32{\%} in vSAA). The optimal dosage of CsA has yet to be established.",
keywords = "Aplastic anaemia, Children, CsA trough level, Cyclosporine A, Immunosuppression",
author = "Alexei Maschan and Natalia Bogatcheva and Oleg Kryjanovskii and Maria Shneider and Dimitry Litvinov and Tatiana Mitiushkina and Andrei Timakov and Maria Timakova and Elena Samotchatova and Alexander Rumiantsev",
year = "1999",
month = "10",
day = "13",
doi = "10.1046/j.1365-2141.1999.01650.x",
language = "English (US)",
volume = "106",
pages = "967--970",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Results at a single centre of immunosuppression with cyclosporine A in 66 children with aplastic anaemia

AU - Maschan, Alexei

AU - Bogatcheva, Natalia

AU - Kryjanovskii, Oleg

AU - Shneider, Maria

AU - Litvinov, Dimitry

AU - Mitiushkina, Tatiana

AU - Timakov, Andrei

AU - Timakova, Maria

AU - Samotchatova, Elena

AU - Rumiantsev, Alexander

PY - 1999/10/13

Y1 - 1999/10/13

N2 - A retrospective analysis of cyclosporine A (CsA) monotherapy administered to 66 children with aplastic anaemia (AA) at a single centre was carried out. The study was conducted on 66 children (F34/M32) with a median age of 10.5 years. 30 children (45%) achieved complete or partial remission within a median of 8 weeks. The response rate was 3/19 (16%) in cases of very severe aplastic anaemia (vSAA), 16/34 (47%) in severe aplastic anaemia (SAA) and 11/13 (85%) in nonSAA. 10 remitters (33%) relapsed after CsA cessation or dose tapering and six of those responded again on CsA alone. The only variable predictive for response was granulocyte count before treatment. The actuarial probability of survival was 51% at 4 years (85% in moderate AA, 50% in SAA and 32% in vSAA). The optimal dosage of CsA has yet to be established.

AB - A retrospective analysis of cyclosporine A (CsA) monotherapy administered to 66 children with aplastic anaemia (AA) at a single centre was carried out. The study was conducted on 66 children (F34/M32) with a median age of 10.5 years. 30 children (45%) achieved complete or partial remission within a median of 8 weeks. The response rate was 3/19 (16%) in cases of very severe aplastic anaemia (vSAA), 16/34 (47%) in severe aplastic anaemia (SAA) and 11/13 (85%) in nonSAA. 10 remitters (33%) relapsed after CsA cessation or dose tapering and six of those responded again on CsA alone. The only variable predictive for response was granulocyte count before treatment. The actuarial probability of survival was 51% at 4 years (85% in moderate AA, 50% in SAA and 32% in vSAA). The optimal dosage of CsA has yet to be established.

KW - Aplastic anaemia

KW - Children

KW - CsA trough level

KW - Cyclosporine A

KW - Immunosuppression

UR - http://www.scopus.com/inward/record.url?scp=0032845580&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032845580&partnerID=8YFLogxK

U2 - 10.1046/j.1365-2141.1999.01650.x

DO - 10.1046/j.1365-2141.1999.01650.x

M3 - Article

C2 - 10519999

AN - SCOPUS:0032845580

VL - 106

SP - 967

EP - 970

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 4

ER -